BIO B — Bio-Rad Laboratories Share News
0.000.00%
Last trade - 00:00- $9.75bn
- $9.34bn
- $2.58bn
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A
U.S. STOCKS ON THE MOVE-Eli Lilly, BlackRock TCP Capital, Boston Scientific
U.S. STOCKS ON THE MOVE-Cognizant, Coursera, ServiceNow
U.S. STOCKS ON THE MOVE-Ford Motor, Intel, Hims & Hers Health
U.S. STOCKS ON THE MOVE-Macy's, Dominion Energy, Bio-Rad Laboratories
Bio‑Rad Laboratories jumps after report Elliott builds stake
Sartorius shares rise after report of Elliott investment
Press Digest: Wall Street Journal - May 18
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports (updated)
Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports
Brief: Activist Elliott Investment Management Has Built A Sizable Stake In Bio-Rad Laboratories- WSJ
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
U.S. STOCKS ON THE MOVE-Perella Weinberg Partners, Amkor Technology, Esperion Therapeutics
Bio-Rad falls after Q1 net loss, cuts 2026 revenue outlook
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International
Bio-Rad posts Q1 net loss on Sartorius AG investment loss, cuts 2026 outlook